diphenyl has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelusi, T; Chowdhry, A; Du, L; Gu, X; Hao, M; Li, X; Lu, Q; Sun, Y; Xu, L; Yin, X; Zhou, X | 1 |
| Ansari, MN; Emiru, YK; Karim, A; Periasamy, G; Ur Rehman, N | 1 |
2 other study(ies) available for diphenyl and Alloxan Diabetes
| Article | Year |
|---|---|
Novel Chalcone BDD-39 Mitigated Diabetic Nephropathy through the Activation of Nrf2/ARE Signaling.
Topics: Animals; Biphenyl Compounds; Chalcone; Chalcones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Mice; NF-E2-Related Factor 2; Oxidative Stress; RNA; Signal Transduction | 2022 |
Evaluation of in vitro α-amylase inhibitory activity and antidiabetic effect of Myrica salicifolia in streptozotocin-induced diabetic mice.
Topics: alpha-Amylases; Animals; Antioxidants; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Female; Hypoglycemic Agents; Male; Mice; Myrica; Phytochemicals; Plant Extracts; Streptozocin | 2020 |